Literature DB >> 15204932

Region at amino acids 164 to 303 of the rabies virus glycoprotein plays an important role in pathogenicity for adult mice.

Mutsuyo Takayama-Ito1, Naoto Ito, Kentaro Yamada, Nobuyuki Minamoto, Makoto Sugiyama.   

Abstract

The authors have previously reported that the glycoprotein of the pathogenic Nishigahara strain of rabies virus is required to lethality for adult mice. A cluster region of amino acid substitutions exists at the positions 164 to 303 on the glycoprotein between avirulent and virulent strains. In this study, the authors generated a chimeric strain having the region at the positions 164 to 303 of the glycoprotein derived from the pathogenic Nishigahara strain in the genetic background of the avirulent RC-HL strain. The chimeric R(G 164-303) strain restores the lethality for adult mice. This result clearly shows that the region at the position 164 to 303 of glycoprotein plays an important role in the lethality for adult mice. Moreover, the authors observed that the lethality for adult mice correlated well with the viral growth in a brain but not with the pH-dependent fusion activity in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15204932     DOI: 10.1080/13550280490279799

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  33 in total

1.  A comparison of complete genome sequences of the attenuated RC-HL strain of rabies virus used for production of animal vaccine in Japan, and the parental Nishigahara strain.

Authors:  N Ito; M Kakemizu; K A Ito; A Yamamoto; Y Yoshida; M Sugiyama; N Minamoto
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

2.  Rabies susceptibility and acetylcholine receptor.

Authors:  G M Baer; J H Shaddock; R Quirion; T V Dam; T L Lentz
Journal:  Lancet       Date:  1990-03-17       Impact factor: 79.321

3.  A unique mutation of glycoprotein gene of the attenuated RC-HL strain of rabies virus, a seed virus used for production of animal vaccine in Japan.

Authors:  H Ito; N Minamoto; T Watanabe; H Goto; L T Rong; M Sugiyama; T Kinjo; K Mannen; K Mifune; T Konobe
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

4.  Rabies virus neuritic paralysis: immunopathogenesis of nonfatal paralytic rabies.

Authors:  F Weiland; J H Cox; S Meyer; E Dahme; M J Reddehase
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Apoptosis induction in brain during the fixed strain of rabies virus infection correlates with onset and severity of illness.

Authors:  S Theerasurakarn; S Ubol
Journal:  J Neurovirol       Date:  1998-08       Impact factor: 2.643

6.  Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.

Authors:  K Morimoto; D C Hooper; S Spitsin; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice.

Authors:  J A Montaño-Hirose; M Lafage; P Weber; H Badrane; N Tordo; M Lafon
Journal:  Vaccine       Date:  1993-09       Impact factor: 3.641

8.  Paralysis of street rabies virus-infected mice is dependent on T lymphocytes.

Authors:  M Sugamata; M Miyazawa; S Mori; G J Spangrude; L C Ewalt; D L Lodmell
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.

Authors:  B Dietzschold; W H Wunner; T J Wiktor; A D Lopes; M Lafon; C L Smith; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.

Authors:  D C Hooper; K Morimoto; M Bette; E Weihe; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more
  7 in total

1.  Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.

Authors:  Naoto Ito; Gregory W Moseley; Danielle Blondel; Kenta Shimizu; Caitlin L Rowe; Yuki Ito; Tatsunori Masatani; Keisuke Nakagawa; David A Jans; Makoto Sugiyama
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

2.  Diagnosis and molecular characterization of rabies virus from a buffalo in China: a case report.

Authors:  Ke-Shan Zhang; Jian-Hong Guo; Zhuo-Fei Xu; Min Xiang; Bin Wu; Huan-Chun Chen
Journal:  Virol J       Date:  2011-03-06       Impact factor: 4.099

3.  Molecular characterization of KGH, the first human isolate of rabies virus in Korea.

Authors:  Jun-Sun Park; Chi-Kyeong Kim; Su Yeon Kim; Young Ran Ju
Journal:  Virus Genes       Date:  2012-12-15       Impact factor: 2.332

4.  Complete genome sequence of a highly virulent rabies virus isolated from a rabid pig in south China.

Authors:  Yongwen Luo; Ying Zhang; Xiangyin Liu; Youtian Yang; Xianfeng Yang; Daiting Zhang; Xianbo Deng; Xiaowei Wu; Xiaofeng Guo
Journal:  J Virol       Date:  2012-11       Impact factor: 5.103

5.  Sequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells.

Authors:  Shimao Zhu; Chunhua Wang; Pei Zhang; Hui Li; Shan Luo; Caiping Guo
Journal:  Virol J       Date:  2014-10-06       Impact factor: 4.099

6.  The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development.

Authors:  Caiping Guo; Chunhua Wang; Shan Luo; Shimao Zhu; Hui Li; Yongdi Liu; Lanzhen Zhou; Pei Zhang; Xin Zhang; Yujiang Ding; Weirong Huang; Kaiyong Wu; Yanpeng Zhang; Weihua Rong; Hua Tian
Journal:  Virol J       Date:  2014-05-12       Impact factor: 4.099

7.  Rabies Internalizes into Primary Peripheral Neurons via Clathrin Coated Pits and Requires Fusion at the Cell Body.

Authors:  Silvia Piccinotti; Sean P J Whelan
Journal:  PLoS Pathog       Date:  2016-07-27       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.